MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds from
issuances of common stock
$21,540,404
Net cash provided by
financing activities
$21,540,404
Net increase
(decrease) in cash and cash...
$6,229,195
Canceled cashflow
$15,311,209
Share-based
compensation-The2025Eloc Facility
$739,935
Share-based
compensation-Excluding Eloc Purchase...
$312,835
Research and development
supplies
-$244,630
Other current
liabilities
$1,690
Net cash used in
operating activities
-$15,311,209
Canceled cashflow
$1,299,090
Net loss
-$16,228,953
Accounts payable
-$331,226
Prepaid expenses and
other
$50,120
Back
Back
Cash Flow
source: myfinsight.com
Genprex, Inc. (GNPX)
Genprex, Inc. (GNPX)